Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Scagliotti · SciRah

Researcher profile · Semantic Scholar

G. Scagliotti

Share profile

G. Scagliotti — researcher profile on SciRah

h-index: 85
Works: 688
Citations: 44K

Most-cited papers

The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.
A. Nicholson, M. Tsao, M. Beasley, A. Borczuk +15 more
2021Journal of Thoracic Oncology1,472 citations Open access
Semantic Scholar
IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY
W. Travis, S. Dacic, I. Wistuba, L. Sholl +39 more
2020Journal of Thoracic Oncology432 citations Open access
Semantic Scholar
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.
J. de Bono, N. Mehra, G. Scagliotti, E. Castro +14 more
2021The Lancet Oncology237 citations Open access
Semantic Scholar
Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC
M. Negrao, H. Araújo, G. Lamberti, Alissa J Cooper +62 more
2023Cancer Discovery136 citations Open access
Semantic Scholar
New approaches to small cell lung cancer therapy : from the laboratory to the clinic
J. Poirier, J. George, T. Owonikoko, A. Berns +43 more
2020Journal of Thoracic Oncology125 citations Open access
Semantic Scholar
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic
A. Dingemans, R. Soo, A. Jazieh, Shawn J. Rice +20 more
2020Journal of Thoracic Oncology77 citations Open access
Semantic Scholar
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval
Benoît Cadieux, R. Coleman, Pegah Jafarinasabian, A. Lipton +5 more
2022Journal of Bone Oncology61 citations Open access
Semantic Scholar
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer
A. Shaw, A. Varghese, B. Solomon, D. Costa +8 more
202146 citations
Semantic Scholar
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside
A. Ungaro, M. Tucci, A. Audisio, L. Di Prima +6 more
2022Cells40 citations Open access
Semantic Scholar
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC.
Fabio Turco, M. Tucci, R. D. Di Stefano, Alessandro Samuelly +6 more
2021Endocrine-Related Cancer37 citations Open access
Semantic Scholar
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018.
P. Lombardi, L. Marandino, E. De Luca, C. Zichi +16 more
2020Critical reviews in oncology/hematology32 citations Open access
Semantic Scholar
Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors
J. Metovic, A. La Salvia, I. Rapa, F. Napoli +7 more
2022Endocrine pathology31 citations Open access
Semantic Scholar
Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won
F. Tabbò, M. L. Reale, P. Bironzo, G. Scagliotti
2020Translational Lung Cancer Research29 citations Open access
Semantic Scholar
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial
G. Filaci, D. Fenoglio, F. Nolè, E. Zanardi +17 more
2021Cancer Immunology and Immunotherapy28 citations Open access
Semantic Scholar
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma
I. Salaroglio, D. Belisario, P. Bironzo, P. Ananthanarayanan +19 more
2022Journal of experimental & clinical cancer research : CR27 citations Open access
Semantic Scholar
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma.
M. Tagliamento, P. Bironzo, H. Curcio, E. De Luca +17 more
2022Critical reviews in oncology/hematology26 citations Open access
Semantic Scholar
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment.
Marika Sculco, Marta La Vecchia, A. Aspesi, G. Pinton +20 more
2022European Journal of Cancer25 citations Open access
Semantic Scholar
A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Non-small-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes: Rationale and Study Design.
F. Passiglia, P. Bironzo, L. Righi, A. Listì +4 more
2020Clinical Lung Cancer22 citations Open access
Semantic Scholar
Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma
F. Napoli, A. Listì, V. Zambelli, Gianluca Witel +5 more
2021Cancers21 citations Open access
Semantic Scholar
Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer
L. Manganaro, S. Bianco, P. Bironzo, F. Cipollini +20 more
2023Scientific Reports19 citations Open access
Semantic Scholar
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer.
D. P. Anobile, I. Salaroglio, F. Tabbò, Sofia La Vecchia +12 more
2023Clinical Cancer Research18 citations Open access
Semantic Scholar
2021 WHO Classification of Lung Cancer: A Globally Applicable and Molecular Biomarker-Relevant Classification.
A. Nicholson, G. Scagliotti, M. Tsao, Y. Yatabe +1 more
2022Journal of Thoracic Oncology18 citations Open access
Semantic Scholar
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review
F. Passiglia, P. Bironzo, V. Bertaglia, A. Listì +2 more
2021Translational Lung Cancer Research18 citations Open access
Semantic Scholar
Real‐world retrospective study of KRAS mutations in advanced non–small cell lung cancer in the era of immunotherapy
P. Bironzo, Massimiliano Cani, F. Jacobs, V. Napoli +6 more
2023Cancer17 citations Open access
Semantic Scholar
The IASLC Early Lung Imaging Confederation (ELIC) Open-Source Deep Learning and Quantitative Measurement Initiative.
S. Lam, M. Wynes, Casey Connolly, Kazuto Ashizawa +26 more
2023Journal of Thoracic Oncology17 citations Open access
Semantic Scholar
International Tailored Chemotherapy Adjuvant (ITACA) Trial, a Phase III Multicenter Randomized Trial Comparing Adjuvant Pharmacogenomic-Driven Chemotherapy versus Standard Adjuvant Chemotherapy in completely Resected Stage II-IIIA Non-Small Cell Lung Cancer.
S. Novello, V. Torri, C. Grohé, S. Kurz +32 more
2021Annals of Oncology17 citations Open access
Semantic Scholar
Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy
E. Garon, G. Scagliotti, O. Gautschi, M. Reck +16 more
2020ESMO Open17 citations Open access
Semantic Scholar
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
R. Rotolo, V. Leuci, C. Donini, F. Galvagno +26 more
2022Clinical Cancer Research15 citations Open access
Semantic Scholar
Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours
D. Dumoulin, P. Bironzo, F. Passiglia, G. Scagliotti +1 more
2023European Respiratory Review14 citations Open access
Semantic Scholar
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses
N. Mehra, K. Fizazi, J. de Bono, P. Barthélémy +14 more
2022The Oncologist14 citations Open access
Semantic Scholar
Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications.
G. Toyokawa, Francesca Bersani, P. Bironzo, F. Picca +8 more
2023Critical reviews in oncology/hematology13 citations Open access
Semantic Scholar
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity
Francesca Bersani, F. Picca, D. Morena, L. Righi +21 more
2023Journal of experimental & clinical cancer research : CR13 citations Open access
Semantic Scholar
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences.
F. Tabbò, L. Muscarella, E. Gobbini, D. Trombetta +25 more
2022European Journal of Cancer13 citations Open access
Semantic Scholar
DNA methylation profiling discriminates between malignant pleural mesothelioma and neoplastic or reactive histological mimics.
L. Bertero, L. Righi, G. Collemi, C. Koelsche +12 more
2021Journal of Molecular Diagnostics13 citations Open access
Semantic Scholar
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations
P. Bironzo, M. L. Reale, Tessa Sperone, F. Tabbò +8 more
2021Cancers13 citations Open access
Semantic Scholar
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with Abiraterone or Enzalutamide.
C. Pisano, M. Tucci, R. D. Di Stefano, Fabio Turco +7 more
2021Minerva urology and nephrology13 citations
Semantic Scholar
Double immune checkpoint blockade in advanced NSCLC.
A. Mariniello, S. Novello, G. Scagliotti, S. Ramalingam
2020Critical reviews in oncology/hematology13 citations
Semantic Scholar
Systemic recurrence of endometrial cancer more than 10 years after hysterectomy: a report of two cases and a brief review of the literature
L. Muratori, P. Sperone, G. Gorzegno, A. La Salvia +1 more
2020Journal of the Egyptian National Cancer Institute13 citations Open access
Semantic Scholar
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
G. Scagliotti, P. Parikh, J. von Pawel, B. Biesma +16 more
2023Journal of Clinical Oncology12 citations
Semantic Scholar
Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1.
F. Saad, J. de Bono, P. Barthélémy, T. Dorff +13 more
2022European Urology12 citations Open access
Semantic Scholar
Therapeutic sequencing in advanced renal cell carcinoma: how to choose considering clinical and biological factors.
M. D. Delcuratolo, M. Tucci, F. Turco, R. D. Di Stefano +8 more
2022Critical reviews in oncology/hematology12 citations
Semantic Scholar
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade
C. Donini, F. Galvagno, R. Rotolo, António Massa +6 more
2023British Journal of Cancer11 citations Open access
Semantic Scholar
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives.
Gianmarco Leone, C. Buttigliero, C. Pisano, R. D. Di Stefano +6 more
2020Critical reviews in oncology/hematology10 citations
Semantic Scholar
Diagnostics of BAP1-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience
Marika Sculco, Marta La Vecchia, A. Aspesi, M. G. Clavenna +27 more
2022Diagnostics9 citations Open access
Semantic Scholar
COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery
M. Bungaro, F. Passiglia, G. Scagliotti
2022Biomedicines9 citations Open access
Semantic Scholar
Humoral immune response to SARS-CoV-2 in five different groups of individuals at different environmental and professional risk of infection
S. Novello, M. Terzolo, Berchialla Paola, M. Gianetta +9 more
2021Scientific Reports9 citations Open access
Semantic Scholar
Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study
J. Ajani, F. El Hajbi, D. Cunningham, M. Alsina +11 more
2023ESMO Open8 citations Open access
Semantic Scholar
New emerging targets in advanced urothelial carcinoma: is it the primetime for personalized medicine?
M. Audisio, M. Tucci, R. D. Di Stefano, E. Parlagreco +8 more
2022Critical reviews in oncology/hematology8 citations
Semantic Scholar
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
F. Turco, M. Tucci, M. D. Delcuratolo, R. D. Di Stefano +8 more
2022Cancer Communications8 citations Open access
Semantic Scholar
Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response.
P. Bironzo, L. Primo, S. Novello, L. Righi +5 more
2022Clinical Lung Cancer8 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Bironzo×18
Invite
P. Bironzo — researcher profile on SciRah
S. Novello×16
Invite
S. Novello — researcher profile on SciRah
L. Righi×13
Invite
L. Righi — researcher profile on SciRah
M. di Maio×12
Invite
M. di Maio — researcher profile on SciRah

×9

Invite

C. Buttigliero — researcher profile on SciRah

Invite

F. Tabbò — researcher profile on SciRah

F. Passiglia×8

Invite

F. Passiglia — researcher profile on SciRah

Invite

M. Papotti — researcher profile on SciRah

Invite

M. Tucci — researcher profile on SciRah

R. D. Di Stefano×7

Invite

R. D. Di Stefano — researcher profile on SciRah

Invite

F. Napoli — researcher profile on SciRah

Invite

A. Listì — researcher profile on SciRah